Latest News & Updates
Breaking News
16 minutes ago
Pharma Now Editorial Team
Pharma Now Editorial Team
Pharma Now Editorial Team
Pharma Now Editorial Team
Pharma Now Editorial Team
Other trending news you may like to read
Bispecific PD-1xVEGF Data in NSCLC Raises Scale-Up Questions for Merck
Merck shares early PD-1xVEGF bispecific data in NSCLC but withholds phase 3 plans, raising questions about GMP scale-up readiness.
Pharma Now Editorial Team
Oral Biologics Push Forces Rethink of Formulation and Manufacturing
Oral biologics and macrocycle drugs are driving new formulation and manufacturing demands that pharma plants must prepare for now.
Pharma Now Editorial Team
Nasal Epinephrine Approval Signals GMP Shifts for Delivery Reformulations
ARS Pharma's nasal epinephrine approval highlights GMP, process validation, and regulatory challenges facing manufacturers pursuing delivery reformulations.
Pharma Now Editorial Team
Xilio's Masked T Cell Engager Data Signal New Approach to Solid Tumor Toxicity
Xilio's preclinical data for masked T cell engager XTX601 show tumor-selective activation and NHP tolerability, with an IND filing planned for 2027.
Pharma Now Editorial Team